SENS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 21.01
- PEG ratio
- 0.00
- P/B
- 10.19
- P/S (TTM)
- 8.55
- EV/EBITDA
- 1.76
Profitability & growth
- ROE (TTM)
- -250.8%
- Operating margin
- -271.9%
- Revenue growth YoY
- 87.2%
- Dividend yield
- —
- Beta
- 0.97
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Senseonics Holdings, Inc. Common Stock
Company profileSenseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
